글로벌 폴리뉴클레오타이드 주사제 시장 2024

■ 영문 제목 : Global Polynucleotides Injectable Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
	■ 상품 코드 : GIR394RG4274 ■ 조사/발행회사 : Globalinforesearch ■ 발행일 : 2024년 12월 ■ 페이지수 : 약120 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (주문 후 2-3영업일) ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,480 ⇒환산￦4,872,000	견적의뢰/주문/질문
Corporate License (동일기업내 공유가능)	USD6,960 ⇒환산￦9,744,000	견적의뢰/주문/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

**Polynucleotides Injectable(폴리뉴클레오타이드 주사제)**는 뉴클레오타이드 단위체로 구성된 고분자인 폴리뉴클레오타이드를 주입하여 조직 재생, 항염, 조직 복구 등의 효과를 기대할 수 있는 의료 및 미용용 주사 치료입니다.
본 보고서는 Global Info Research가 수행한 최신 연구 결과로, 전 세계 Polynucleotides Injectable 시장의 규모, 경쟁 상황, 수요·공급 동향, 지역별 분석, 제품 유형 및 응용 분야별 세분화 전망 등을 종합적으로 다루고 있습니다. 특히 2023년 기준 시장 데이터를 바탕으로 2030년까지의 시장 성장 예측을 포함하고 있습니다.

■ 보고서의 핵심 내용
• 시장 규모 및 성장률 예측
2019년부터 2030년까지의 기간 동안 소비 금액(백만 달러), 판매량(킬로톤), 평균 판매 가격(US$/톤) 기준으로 시장 규모를 예측합니다.
• 정량 및 정성 분석
제조업체, 국가/지역, 제품 유형, 응용 분야 별로 세분화하여 데이터 분석이 이루어졌습니다.
• 경쟁 구도 분석
주요 기업들의 매출, 판매량, 평균 단가, 점유율 등을 통해 시장 내 경쟁 구조를 파악하였으며, 대표 기업들의 제품 포트폴리오, 지역 확장, 주요 개발 사항도 포함됩니다.
• 시장 동력 및 제약 요인
주요 성장 요인, 억제 요인, 트렌드, 신규 제품 출시 및 승인 등 시장 변화에 영향을 미치는 요인들을 종합적으로 분석합니다.

■ 시장 세분화
• 제품 유형별
o 눈가
o 입술
o 이마
o 턱선 및 광대
o 기타
• 응용 분야별
o MedSpas
o 미용 및 에스테틱 센터
o 병원

■ 지역별 분석
• 북미: 미국, 캐나다, 멕시코
• 유럽: 독일, 프랑스, 영국, 러시아, 이탈리아 등
• 아시아 태평양: 중국, 일본, 한국, 인도, 동남아, 호주 등
• 남미: 브라질, 아르헨티나, 콜롬비아 등
• 중동 및 아프리카: 사우디아라비아, UAE, 이집트, 남아프리카공화국 등

■ 보고서 개요

Polynucleotides injectables refer to medical and cosmetic treatments involving the injection of polynucleotide compounds, which are polymers composed of nucleotide monomers. These injectables are used in various applications due to their regenerative, anti-inflammatory, and tissue-repairing properties.

According to our (Global Info Research) latest study, the global Polynucleotides Injectable market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Polynucleotides Injectable market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Polynucleotides Injectable market size and forecasts, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2019-2030
Global Polynucleotides Injectable market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2019-2030
Global Polynucleotides Injectable market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2019-2030
Global Polynucleotides Injectable market shares of main players, shipments in revenue ($ Million), sales quantity (Kilotons), and ASP (US$/Ton), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Polynucleotides Injectable
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Polynucleotides Injectable market based on the following parameters – company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PharmaResearch Products Co., Ltd., Mastelli Srl, Promoitalia Group S.p.A., GUNA S.p.A., Caregen Co., Ltd., Medytox Inc., Suneva Medical, Inc., Euroresearch S.r.l., Anteis SA (now part of Merz Pharmaceuticals), Hyundai Pharm Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Polynucleotides Injectable market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Eyes
Lips
Forehead
Jawline & Cheekbones
Others

Market segment by Application
MedSpas
Aesthetic & Cosmetic Centers
Hospitals

Major players covered
PharmaResearch Products Co., Ltd.
Mastelli Srl
Promoitalia Group S.p.A.
GUNA S.p.A.
Caregen Co., Ltd.
Medytox Inc.
Suneva Medical, Inc.
Euroresearch S.r.l.
Anteis SA (now part of Merz Pharmaceuticals)
Hyundai Pharm Co., Ltd.
Regen Biotech, Inc.
Evolus, Inc.
Cleviel
Promedica International
NeoGenesis Co., Ltd.

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polynucleotides Injectable product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Polynucleotides Injectable, with price, sales quantity, revenue, and global market share of Polynucleotides Injectable from 2019 to 2024.
Chapter 3, the Polynucleotides Injectable competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polynucleotides Injectable breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Polynucleotides Injectable market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Polynucleotides Injectable.
Chapter 14 and 15, to describe Polynucleotides Injectable sales channel, distributors, customers, research findings and conclusion.

■ 보고서 목차

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Polynucleotides Injectable Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Eyes
1.3.3 Lips
1.3.4 Forehead
1.3.5 Jawline & Cheekbones
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Polynucleotides Injectable Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 MedSpas
1.4.3 Aesthetic & Cosmetic Centers
1.4.4 Hospitals
1.5 Global Polynucleotides Injectable Market Size & Forecast
1.5.1 Global Polynucleotides Injectable Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Polynucleotides Injectable Sales Quantity (2019-2030)
1.5.3 Global Polynucleotides Injectable Average Price (2019-2030)

2 Manufacturers Profiles
2.1 PharmaResearch Products Co., Ltd.
2.1.1 PharmaResearch Products Co., Ltd. Details
2.1.2 PharmaResearch Products Co., Ltd. Major Business
2.1.3 PharmaResearch Products Co., Ltd. Polynucleotides Injectable Product and Services
2.1.4 PharmaResearch Products Co., Ltd. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 PharmaResearch Products Co., Ltd. Recent Developments/Updates
2.2 Mastelli Srl
2.2.1 Mastelli Srl Details
2.2.2 Mastelli Srl Major Business
2.2.3 Mastelli Srl Polynucleotides Injectable Product and Services
2.2.4 Mastelli Srl Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Mastelli Srl Recent Developments/Updates
2.3 Promoitalia Group S.p.A.
2.3.1 Promoitalia Group S.p.A. Details
2.3.2 Promoitalia Group S.p.A. Major Business
2.3.3 Promoitalia Group S.p.A. Polynucleotides Injectable Product and Services
2.3.4 Promoitalia Group S.p.A. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Promoitalia Group S.p.A. Recent Developments/Updates
2.4 GUNA S.p.A.
2.4.1 GUNA S.p.A. Details
2.4.2 GUNA S.p.A. Major Business
2.4.3 GUNA S.p.A. Polynucleotides Injectable Product and Services
2.4.4 GUNA S.p.A. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GUNA S.p.A. Recent Developments/Updates
2.5 Caregen Co., Ltd.
2.5.1 Caregen Co., Ltd. Details
2.5.2 Caregen Co., Ltd. Major Business
2.5.3 Caregen Co., Ltd. Polynucleotides Injectable Product and Services
2.5.4 Caregen Co., Ltd. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Caregen Co., Ltd. Recent Developments/Updates
2.6 Medytox Inc.
2.6.1 Medytox Inc. Details
2.6.2 Medytox Inc. Major Business
2.6.3 Medytox Inc. Polynucleotides Injectable Product and Services
2.6.4 Medytox Inc. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Medytox Inc. Recent Developments/Updates
2.7 Suneva Medical, Inc.
2.7.1 Suneva Medical, Inc. Details
2.7.2 Suneva Medical, Inc. Major Business
2.7.3 Suneva Medical, Inc. Polynucleotides Injectable Product and Services
2.7.4 Suneva Medical, Inc. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Suneva Medical, Inc. Recent Developments/Updates
2.8 Euroresearch S.r.l.
2.8.1 Euroresearch S.r.l. Details
2.8.2 Euroresearch S.r.l. Major Business
2.8.3 Euroresearch S.r.l. Polynucleotides Injectable Product and Services
2.8.4 Euroresearch S.r.l. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Euroresearch S.r.l. Recent Developments/Updates
2.9 Anteis SA (now part of Merz Pharmaceuticals)
2.9.1 Anteis SA (now part of Merz Pharmaceuticals) Details
2.9.2 Anteis SA (now part of Merz Pharmaceuticals) Major Business
2.9.3 Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Product and Services
2.9.4 Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Anteis SA (now part of Merz Pharmaceuticals) Recent Developments/Updates
2.10 Hyundai Pharm Co., Ltd.
2.10.1 Hyundai Pharm Co., Ltd. Details
2.10.2 Hyundai Pharm Co., Ltd. Major Business
2.10.3 Hyundai Pharm Co., Ltd. Polynucleotides Injectable Product and Services
2.10.4 Hyundai Pharm Co., Ltd. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Hyundai Pharm Co., Ltd. Recent Developments/Updates
2.11 Regen Biotech, Inc.
2.11.1 Regen Biotech, Inc. Details
2.11.2 Regen Biotech, Inc. Major Business
2.11.3 Regen Biotech, Inc. Polynucleotides Injectable Product and Services
2.11.4 Regen Biotech, Inc. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Regen Biotech, Inc. Recent Developments/Updates
2.12 Evolus, Inc.
2.12.1 Evolus, Inc. Details
2.12.2 Evolus, Inc. Major Business
2.12.3 Evolus, Inc. Polynucleotides Injectable Product and Services
2.12.4 Evolus, Inc. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Evolus, Inc. Recent Developments/Updates
2.13 Cleviel
2.13.1 Cleviel Details
2.13.2 Cleviel Major Business
2.13.3 Cleviel Polynucleotides Injectable Product and Services
2.13.4 Cleviel Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Cleviel Recent Developments/Updates
2.14 Promedica International
2.14.1 Promedica International Details
2.14.2 Promedica International Major Business
2.14.3 Promedica International Polynucleotides Injectable Product and Services
2.14.4 Promedica International Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Promedica International Recent Developments/Updates
2.15 NeoGenesis Co., Ltd.
2.15.1 NeoGenesis Co., Ltd. Details
2.15.2 NeoGenesis Co., Ltd. Major Business
2.15.3 NeoGenesis Co., Ltd. Polynucleotides Injectable Product and Services
2.15.4 NeoGenesis Co., Ltd. Polynucleotides Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 NeoGenesis Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Polynucleotides Injectable by Manufacturer
3.1 Global Polynucleotides Injectable Sales Quantity by Manufacturer (2019-2024)
3.2 Global Polynucleotides Injectable Revenue by Manufacturer (2019-2024)
3.3 Global Polynucleotides Injectable Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Polynucleotides Injectable by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Polynucleotides Injectable Manufacturer Market Share in 2023
3.4.3 Top 6 Polynucleotides Injectable Manufacturer Market Share in 2023
3.5 Polynucleotides Injectable Market: Overall Company Footprint Analysis
3.5.1 Polynucleotides Injectable Market: Region Footprint
3.5.2 Polynucleotides Injectable Market: Company Product Type Footprint
3.5.3 Polynucleotides Injectable Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Polynucleotides Injectable Market Size by Region
4.1.1 Global Polynucleotides Injectable Sales Quantity by Region (2019-2030)
4.1.2 Global Polynucleotides Injectable Consumption Value by Region (2019-2030)
4.1.3 Global Polynucleotides Injectable Average Price by Region (2019-2030)
4.2 North America Polynucleotides Injectable Consumption Value (2019-2030)
4.3 Europe Polynucleotides Injectable Consumption Value (2019-2030)
4.4 Asia-Pacific Polynucleotides Injectable Consumption Value (2019-2030)
4.5 South America Polynucleotides Injectable Consumption Value (2019-2030)
4.6 Middle East & Africa Polynucleotides Injectable Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Polynucleotides Injectable Sales Quantity by Type (2019-2030)
5.2 Global Polynucleotides Injectable Consumption Value by Type (2019-2030)
5.3 Global Polynucleotides Injectable Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Polynucleotides Injectable Sales Quantity by Application (2019-2030)
6.2 Global Polynucleotides Injectable Consumption Value by Application (2019-2030)
6.3 Global Polynucleotides Injectable Average Price by Application (2019-2030)

7 North America
7.1 North America Polynucleotides Injectable Sales Quantity by Type (2019-2030)
7.2 North America Polynucleotides Injectable Sales Quantity by Application (2019-2030)
7.3 North America Polynucleotides Injectable Market Size by Country
7.3.1 North America Polynucleotides Injectable Sales Quantity by Country (2019-2030)
7.3.2 North America Polynucleotides Injectable Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Polynucleotides Injectable Sales Quantity by Type (2019-2030)
8.2 Europe Polynucleotides Injectable Sales Quantity by Application (2019-2030)
8.3 Europe Polynucleotides Injectable Market Size by Country
8.3.1 Europe Polynucleotides Injectable Sales Quantity by Country (2019-2030)
8.3.2 Europe Polynucleotides Injectable Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Polynucleotides Injectable Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Polynucleotides Injectable Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Polynucleotides Injectable Market Size by Region
9.3.1 Asia-Pacific Polynucleotides Injectable Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Polynucleotides Injectable Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Polynucleotides Injectable Sales Quantity by Type (2019-2030)
10.2 South America Polynucleotides Injectable Sales Quantity by Application (2019-2030)
10.3 South America Polynucleotides Injectable Market Size by Country
10.3.1 South America Polynucleotides Injectable Sales Quantity by Country (2019-2030)
10.3.2 South America Polynucleotides Injectable Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Polynucleotides Injectable Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Polynucleotides Injectable Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Polynucleotides Injectable Market Size by Country
11.3.1 Middle East & Africa Polynucleotides Injectable Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Polynucleotides Injectable Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Polynucleotides Injectable Market Drivers
12.2 Polynucleotides Injectable Market Restraints
12.3 Polynucleotides Injectable Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Polynucleotides Injectable and Key Manufacturers
13.2 Manufacturing Costs Percentage of Polynucleotides Injectable
13.3 Polynucleotides Injectable Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Polynucleotides Injectable Typical Distributors
14.3 Polynucleotides Injectable Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Polynucleotides Injectable Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Polynucleotides Injectable Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. PharmaResearch Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. PharmaResearch Products Co., Ltd. Major Business
Table 5. PharmaResearch Products Co., Ltd. Polynucleotides Injectable Product and Services
Table 6. PharmaResearch Products Co., Ltd. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. PharmaResearch Products Co., Ltd. Recent Developments/Updates
Table 8. Mastelli Srl Basic Information, Manufacturing Base and Competitors
Table 9. Mastelli Srl Major Business
Table 10. Mastelli Srl Polynucleotides Injectable Product and Services
Table 11. Mastelli Srl Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Mastelli Srl Recent Developments/Updates
Table 13. Promoitalia Group S.p.A. Basic Information, Manufacturing Base and Competitors
Table 14. Promoitalia Group S.p.A. Major Business
Table 15. Promoitalia Group S.p.A. Polynucleotides Injectable Product and Services
Table 16. Promoitalia Group S.p.A. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Promoitalia Group S.p.A. Recent Developments/Updates
Table 18. GUNA S.p.A. Basic Information, Manufacturing Base and Competitors
Table 19. GUNA S.p.A. Major Business
Table 20. GUNA S.p.A. Polynucleotides Injectable Product and Services
Table 21. GUNA S.p.A. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. GUNA S.p.A. Recent Developments/Updates
Table 23. Caregen Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Caregen Co., Ltd. Major Business
Table 25. Caregen Co., Ltd. Polynucleotides Injectable Product and Services
Table 26. Caregen Co., Ltd. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Caregen Co., Ltd. Recent Developments/Updates
Table 28. Medytox Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Medytox Inc. Major Business
Table 30. Medytox Inc. Polynucleotides Injectable Product and Services
Table 31. Medytox Inc. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Medytox Inc. Recent Developments/Updates
Table 33. Suneva Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Suneva Medical, Inc. Major Business
Table 35. Suneva Medical, Inc. Polynucleotides Injectable Product and Services
Table 36. Suneva Medical, Inc. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Suneva Medical, Inc. Recent Developments/Updates
Table 38. Euroresearch S.r.l. Basic Information, Manufacturing Base and Competitors
Table 39. Euroresearch S.r.l. Major Business
Table 40. Euroresearch S.r.l. Polynucleotides Injectable Product and Services
Table 41. Euroresearch S.r.l. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Euroresearch S.r.l. Recent Developments/Updates
Table 43. Anteis SA (now part of Merz Pharmaceuticals) Basic Information, Manufacturing Base and Competitors
Table 44. Anteis SA (now part of Merz Pharmaceuticals) Major Business
Table 45. Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Product and Services
Table 46. Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Anteis SA (now part of Merz Pharmaceuticals) Recent Developments/Updates
Table 48. Hyundai Pharm Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Hyundai Pharm Co., Ltd. Major Business
Table 50. Hyundai Pharm Co., Ltd. Polynucleotides Injectable Product and Services
Table 51. Hyundai Pharm Co., Ltd. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Hyundai Pharm Co., Ltd. Recent Developments/Updates
Table 53. Regen Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Regen Biotech, Inc. Major Business
Table 55. Regen Biotech, Inc. Polynucleotides Injectable Product and Services
Table 56. Regen Biotech, Inc. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Regen Biotech, Inc. Recent Developments/Updates
Table 58. Evolus, Inc. Basic Information, Manufacturing Base and Competitors
Table 59. Evolus, Inc. Major Business
Table 60. Evolus, Inc. Polynucleotides Injectable Product and Services
Table 61. Evolus, Inc. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Evolus, Inc. Recent Developments/Updates
Table 63. Cleviel Basic Information, Manufacturing Base and Competitors
Table 64. Cleviel Major Business
Table 65. Cleviel Polynucleotides Injectable Product and Services
Table 66. Cleviel Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Cleviel Recent Developments/Updates
Table 68. Promedica International Basic Information, Manufacturing Base and Competitors
Table 69. Promedica International Major Business
Table 70. Promedica International Polynucleotides Injectable Product and Services
Table 71. Promedica International Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Promedica International Recent Developments/Updates
Table 73. NeoGenesis Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. NeoGenesis Co., Ltd. Major Business
Table 75. NeoGenesis Co., Ltd. Polynucleotides Injectable Product and Services
Table 76. NeoGenesis Co., Ltd. Polynucleotides Injectable Sales Quantity (Kilotons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. NeoGenesis Co., Ltd. Recent Developments/Updates
Table 78. Global Polynucleotides Injectable Sales Quantity by Manufacturer (2019-2024) & (Kilotons)
Table 79. Global Polynucleotides Injectable Revenue by Manufacturer (2019-2024) & (USD Million)
Table 80. Global Polynucleotides Injectable Average Price by Manufacturer (2019-2024) & (US$/Ton)
Table 81. Market Position of Manufacturers in Polynucleotides Injectable, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 82. Head Office and Polynucleotides Injectable Production Site of Key Manufacturer
Table 83. Polynucleotides Injectable Market: Company Product Type Footprint
Table 84. Polynucleotides Injectable Market: Company Product Application Footprint
Table 85. Polynucleotides Injectable New Market Entrants and Barriers to Market Entry
Table 86. Polynucleotides Injectable Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Polynucleotides Injectable Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 88. Global Polynucleotides Injectable Sales Quantity by Region (2019-2024) & (Kilotons)
Table 89. Global Polynucleotides Injectable Sales Quantity by Region (2025-2030) & (Kilotons)
Table 90. Global Polynucleotides Injectable Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Global Polynucleotides Injectable Consumption Value by Region (2025-2030) & (USD Million)
Table 92. Global Polynucleotides Injectable Average Price by Region (2019-2024) & (US$/Ton)
Table 93. Global Polynucleotides Injectable Average Price by Region (2025-2030) & (US$/Ton)
Table 94. Global Polynucleotides Injectable Sales Quantity by Type (2019-2024) & (Kilotons)
Table 95. Global Polynucleotides Injectable Sales Quantity by Type (2025-2030) & (Kilotons)
Table 96. Global Polynucleotides Injectable Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Global Polynucleotides Injectable Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Global Polynucleotides Injectable Average Price by Type (2019-2024) & (US$/Ton)
Table 99. Global Polynucleotides Injectable Average Price by Type (2025-2030) & (US$/Ton)
Table 100. Global Polynucleotides Injectable Sales Quantity by Application (2019-2024) & (Kilotons)
Table 101. Global Polynucleotides Injectable Sales Quantity by Application (2025-2030) & (Kilotons)
Table 102. Global Polynucleotides Injectable Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Global Polynucleotides Injectable Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Global Polynucleotides Injectable Average Price by Application (2019-2024) & (US$/Ton)
Table 105. Global Polynucleotides Injectable Average Price by Application (2025-2030) & (US$/Ton)
Table 106. North America Polynucleotides Injectable Sales Quantity by Type (2019-2024) & (Kilotons)
Table 107. North America Polynucleotides Injectable Sales Quantity by Type (2025-2030) & (Kilotons)
Table 108. North America Polynucleotides Injectable Sales Quantity by Application (2019-2024) & (Kilotons)
Table 109. North America Polynucleotides Injectable Sales Quantity by Application (2025-2030) & (Kilotons)
Table 110. North America Polynucleotides Injectable Sales Quantity by Country (2019-2024) & (Kilotons)
Table 111. North America Polynucleotides Injectable Sales Quantity by Country (2025-2030) & (Kilotons)
Table 112. North America Polynucleotides Injectable Consumption Value by Country (2019-2024) & (USD Million)
Table 113. North America Polynucleotides Injectable Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Europe Polynucleotides Injectable Sales Quantity by Type (2019-2024) & (Kilotons)
Table 115. Europe Polynucleotides Injectable Sales Quantity by Type (2025-2030) & (Kilotons)
Table 116. Europe Polynucleotides Injectable Sales Quantity by Application (2019-2024) & (Kilotons)
Table 117. Europe Polynucleotides Injectable Sales Quantity by Application (2025-2030) & (Kilotons)
Table 118. Europe Polynucleotides Injectable Sales Quantity by Country (2019-2024) & (Kilotons)
Table 119. Europe Polynucleotides Injectable Sales Quantity by Country (2025-2030) & (Kilotons)
Table 120. Europe Polynucleotides Injectable Consumption Value by Country (2019-2024) & (USD Million)
Table 121. Europe Polynucleotides Injectable Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Asia-Pacific Polynucleotides Injectable Sales Quantity by Type (2019-2024) & (Kilotons)
Table 123. Asia-Pacific Polynucleotides Injectable Sales Quantity by Type (2025-2030) & (Kilotons)
Table 124. Asia-Pacific Polynucleotides Injectable Sales Quantity by Application (2019-2024) & (Kilotons)
Table 125. Asia-Pacific Polynucleotides Injectable Sales Quantity by Application (2025-2030) & (Kilotons)
Table 126. Asia-Pacific Polynucleotides Injectable Sales Quantity by Region (2019-2024) & (Kilotons)
Table 127. Asia-Pacific Polynucleotides Injectable Sales Quantity by Region (2025-2030) & (Kilotons)
Table 128. Asia-Pacific Polynucleotides Injectable Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Asia-Pacific Polynucleotides Injectable Consumption Value by Region (2025-2030) & (USD Million)
Table 130. South America Polynucleotides Injectable Sales Quantity by Type (2019-2024) & (Kilotons)
Table 131. South America Polynucleotides Injectable Sales Quantity by Type (2025-2030) & (Kilotons)
Table 132. South America Polynucleotides Injectable Sales Quantity by Application (2019-2024) & (Kilotons)
Table 133. South America Polynucleotides Injectable Sales Quantity by Application (2025-2030) & (Kilotons)
Table 134. South America Polynucleotides Injectable Sales Quantity by Country (2019-2024) & (Kilotons)
Table 135. South America Polynucleotides Injectable Sales Quantity by Country (2025-2030) & (Kilotons)
Table 136. South America Polynucleotides Injectable Consumption Value by Country (2019-2024) & (USD Million)
Table 137. South America Polynucleotides Injectable Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Middle East & Africa Polynucleotides Injectable Sales Quantity by Type (2019-2024) & (Kilotons)
Table 139. Middle East & Africa Polynucleotides Injectable Sales Quantity by Type (2025-2030) & (Kilotons)
Table 140. Middle East & Africa Polynucleotides Injectable Sales Quantity by Application (2019-2024) & (Kilotons)
Table 141. Middle East & Africa Polynucleotides Injectable Sales Quantity by Application (2025-2030) & (Kilotons)
Table 142. Middle East & Africa Polynucleotides Injectable Sales Quantity by Country (2019-2024) & (Kilotons)
Table 143. Middle East & Africa Polynucleotides Injectable Sales Quantity by Country (2025-2030) & (Kilotons)
Table 144. Middle East & Africa Polynucleotides Injectable Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Middle East & Africa Polynucleotides Injectable Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Polynucleotides Injectable Raw Material
Table 147. Key Manufacturers of Polynucleotides Injectable Raw Materials
Table 148. Polynucleotides Injectable Typical Distributors
Table 149. Polynucleotides Injectable Typical Customers

※본 조사보고서 [글로벌 폴리뉴클레오타이드 주사제 시장 2024] (코드 : GIR394RG4274) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 폴리뉴클레오타이드 주사제 시장 2024] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!